Artificial intelligence (AI) isn't the only industry with explosive growth potential.

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of ...

Hands-on biotech training delivers credentials, research projects, and real lab access for San Antonio students—fueling ...

Amgen Inc. (NASDAQ:AMGN) is included among the 12 Best Dow Jones Dividend Stocks to Buy According to Hedge Funds. On January ...

SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

A life sciences hub in Syracuse is getting a major upgrade as New York pushes to grow its biotechnology sector. Gov. Kathy ...

Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRSP), has come under renewed pressure in recent weeks, ...

A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...

Loopworm owns and operates its primary production facility in Bangalore, with a current capacity of 6,000 tons annually.

Now, it’s worth noting Stock Advisor’s total average return is 949 % — a market-crushing outperformance compared to 195% for ...